Soluble guanylate cyclase: a potential therapeutic target for heart
Published: Jan 1, 2013
Abstract
The number of annual hospitalizations for heart failure (HF) and the mortality rates among patients hospi- talized for HF remains unacceptably high. The search continues for safe and effective agents that improve out- comes when added to standard therapy. The nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) pathway serves an important physiologic role in both vascular and non-vascular tissues, including...
Paper Details
Title
Soluble guanylate cyclase: a potential therapeutic target for heart
Published Date
Jan 1, 2013
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History